Ascendis Pharma A/S (ASND)
NASDAQ: ASND · Real-Time Price · USD
216.66
+1.08 (0.50%)
At close: Jan 21, 2026, 4:00 PM EST
216.66
0.00 (0.00%)
After-hours: Jan 21, 2026, 4:10 PM EST
Ascendis Pharma Market Cap
Ascendis Pharma has a market cap or net worth of $13.3 billion as of January 21, 2026. Its market cap has increased by 67.49% in one year.
Market Cap
13.30B
Enterprise Value
13.28B
1-Year Change
67.49%
Ranking
Category
Stock Price
$216.66
Market Cap Chart
Since January 28, 2015, Ascendis Pharma's market cap has increased from $448.80M to $13.30B, an increase of 2,863.16%. That is a compound annual growth rate of 36.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 13.17B | 1.10% |
| Dec 31, 2025 | 13.03B | 64.48% |
| Dec 31, 2024 | 7.92B | 9.08% |
| Dec 29, 2023 | 7.26B | 4.27% |
| Dec 30, 2022 | 6.96B | -3.83% |
| Dec 31, 2021 | 7.24B | -17.63% |
| Dec 31, 2020 | 8.79B | 32.38% |
| Dec 31, 2019 | 6.64B | 152.21% |
| Dec 31, 2018 | 2.63B | 80.76% |
| Dec 29, 2017 | 1.46B | 185.54% |
| Dec 30, 2016 | 510.20M | 10.84% |
| Dec 31, 2015 | 460.30M | 2.56% |
| Jan 28, 2015 | 448.80M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Moderna | 16.52B |
| Roivant Sciences | 15.74B |
| BridgeBio Pharma | 14.73B |
| Summit Therapeutics | 12.82B |
| Ionis Pharmaceuticals | 12.25B |
| Exelixis | 11.77B |
| Madrigal Pharmaceuticals | 11.17B |
| Avidity Biosciences | 10.93B |